We therefore investigated whether ELK1 could affect the viability and migration of AR-positive bladder cancer cells in the absence of androgens and whether androgen could enhance the viability and migration of AR-positive ELK1-shRNA-expressing bladder cancer cells. The gene discussed is AR; the disease is urinary bladder carcinoma.